Search

Your search keyword '"Chris Bower"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Chris Bower" Remove constraint Author: "Chris Bower" Topic microbiology Remove constraint Topic: microbiology
19 results on '"Chris Bower"'

Search Results

1. Clinical and Genomic Epidemiology of mcr-9-Carrying Carbapenem-Resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012 to 2017

2. Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States

Catalog

Books, media, physical & digital resources

3. Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States

4. Evaluation of Discrepancies in Carbapenem Minimum Inhibitory Concentrations Obtained at Clinical Laboratories Compared to a Public Health Laboratory

5. Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States

6. 834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018

7. Carbapenem-Resistant Acinetobacter baumannii Incidence Trends Identified Through the Emerging Infections Program, 2012–2018

8. Characteristics Associated with Death in Patients with Carbapenem-Resistant Acinetobacter baumannii, United States, 2012–2017

9. Epidemiologic Characteristics of ESBL-Producing ST131 E. coli Identified Through the Emerging Infections Program, 2017

10. Characterization of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant Enterobacteriaceae, United States, 2015–2017

11. Carbapenem-Resistant Enterobacteriaceae Resistant Only to Ertapenem: An Epidemiologically Distinct Cohort, Atlanta, 2016–2018

12. 1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016

13. 507. Epidemiology of Community-Associated Carbapenemase + Producing Carbapenem-Resistant Enterobacteriacae Identified from the Emerging Infections Program, 2012–2017

14. 486. Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2018

15. Surveillance for Carbapenem-Resistant Pseudomonas aeruginosa at Five United States Sites—2015

17. Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) in 6 US communities

18. Comparison of 30- and 90-Day Mortality Rates in Patients with Cultures Positive for Carbapenem-resistant Enterobacteriaceae and Acinetobacter in Atlanta, 2011–2015

19. A CLK1-KKT2 signaling pathway regulating kinetochore assembly in Trypanosoma brucei